Skip to main content

Universal DX

Scientist II, Reagent QC Development

Dallas Fort-Worth

Location
Dallas Fort-Worth
Work
Not stated
Employment
Not stated
Level
Mid level
Function
Science & research
Pay
Not stated
Posted
6 weeks ago

About the role

About our Company

Universal DX, Inc. is an international Company with a highly experienced team focused on cracking cancer’s code. Through our multi-omics and bioinformatics models, we have figured out how to read the disease’s signals in blood with high accuracy to detect cancer in its earliest stages. Starting with a colorectal cancer screening liquid biopsy test, we are building a multi-cancer platform that can identify the unique DNA regions associated with different types of cancers.

The Opportunity

We are seeking a highly motivated Scientist II specializing in Reagent QC Development to join our rapidly growing team. This role will play a critical role in developing and executing quality control (QC) methods for reagents used in our NGS-based diagnostic assays. Reporting to the Director, Reagent Development, this role will oversee reagent QC method development as well as establish reagent stability to ensure robust assay performance and compliance with regulatory standards. This role will also play an integral role in coordinating the transfer of reagent QC methods and related documentation to the Reagent Manufacturing team.

You will be part of a team that is passionate about developing novel diagnostic tests for the early detection of cancers. As part of the team, you will be in a Company that aims more than to become one of the leaders in the industry. We want to have a huge positive impact on society by achieving the ambitious purpose of “making cancer a curable disease by detecting it earlier”.

How you’ll contribute

Reagent QC Method Development:

  • Support the development and validation of QC methods for assay-critical reagents used in next-generation sequencing (NGS)-based in vitro diagnostic (IVD) assays, ensuring accuracy, reliability, and compliance with CLSI guidelines and regulatory standards.
  • Design and implement studies to support a comprehensive validation framework for reagent QC methods for NGS workflows.
  • Optimize and scale QC workflows to enhance efficiency, reproducibility, and robustness, integrating risk-based approaches to reagent quality control.

Reagent Stability Studies:

  • Design and execute studies to establish the in use and long-term stability of reagents, ensuring long-term reliability.
  • Partner with Data science team to analyze stability data and determine reagent shelf life and usage guidelines.

Documentation and Reporting:

  • Draft and review study protocols, validation reports, and other technical documentation.
  • Ensure thorough and accurate record-keeping to support regulatory submissions and audits.

Cross-Functional Collaboration:

  • Partner with internal teams, including Manufacturing, Quality Assurance, and Regulatory Affairs, to ensure seamless integration of reagent QC strategies across the product lifecycle
  • Collaborate with internal and external partners to facilitate process transfer and QC testing.

Process Optimization and Compliance:

  • Identify opportunities for process improvement and implement solutions to enhance efficiency and reproducibility.
  • Maintain adherence to quality management systems (QMS) and regulatory compliance throughout all QC activities.

What you’ll bring

Required:

  • Master’s degree or Ph.D. in Molecular Biology, Biochemistry, Genetics, or a related field.
  • 3+ years of experience in product development (assay and/or reagent and/or QC methods development)for NGS-based IVD assays.
  • Familiarity with regulatory requirements (e.g., FDA, IVDR) and industry standards (e.g., CLSI guidelines).
  • Proven ability to design and manage validation studies.
  • Excellent analytical, problem-solving, and project management skills.
  • Comfortable working in fast-paced environment with ability to adapt to shifting priorities.

Preferred:

  • Understanding of reagent QC method development, including functional and stability testing.
  • Experience in oncology diagnostics or liquid biopsy assays.
  • Familiarity with automation systems and high-throughput platforms.
  • Prior experience transferring reagent QC methods from R&D to Manufacturing teams.

What we´ll offer

  • 22 days of PTO with the possibility to carry over 10 days to the following year.
  • Company Holidays, plus your Birthday off!
  • Company-sponsored benefit plans, including medical, dental, and vision insurance plus life, STD, and LTD coverage, and 401(k).
  • Flexible work schedule
  • And more to come!

Why Now?

This is an exciting time to be at Universal DX. We are growing rapidly and starting our US operations by building up our team, starting our lab and business operations, and establishing strategic partnerships.

We are looking for passionate changemakers to be a part of our journey in this expansive time for us.

Source

Posted by Universal DX on their own hiring page, www.universaldx.com. OptiTalent shows it as published, read 07 Nov 2026 08:42 UTC; the original is the reference.

View the original ad ↗

More at Universal DX

  • Legal Counsel

    3 days ago

    Universal DX · United States

    SeniorLegal & compliance

    Universal DX is seeking an experienced Legal Counsel to support its US business, including its laboratory operations in Dallas, Texas. As part of an international Legal team, you will advise on clinical research, commercial activities and corporate matters, helping the business…

  • Universal DX · Dallas Fort-Worth

    Operations

    Universal Diagnostics (UDx) is seeking an Biomedical Equipment Manager to join our Lab Operations Team in the Dallas-Fort Worth, TX area. In this role, you will lead equipment operations through equipment readiness, scheduling, maintenance, calibration, qualification, and…

  • Universal DX · Dallas Fort Worth

    Entry levelScience & research

    Universal DX is seeking an R&D Research Associate to support the continued development and refinement of Signal-C, our next-generation sequencing (NGS) assay for colorectal cancer screening. You will execute customized study protocols with training and guidance from scientists,…